智通财经APP讯，春立医疗(01858)公布2025年中期业绩，营业收入约4.88亿元，同比增长28.27%;归属于上市公司股东的净利润约1.14亿元，同比增长44.85%;基本每股收益0.3元。
公告称，收入增长主要系报告期内稳定供应集采产品，销量持续增长。另外公司稳步推进国际市场的开拓工作，出口业务持续攀升。
净利增长主要系报告期内公司稳定供应集采产品、深度拓展国际市场，推动销量增长;同时内部降本增效，强化核心业务竞争力，内外并举推动盈利能力稳步提升，实现了净利润的持续增长。
智通财经APP讯，春立医疗(01858)公布2025年中期业绩，营业收入约4.88亿元，同比增长28.27%;归属于上市公司股东的净利润约1.14亿元，同比增长44.85%;基本每股收益0.3元。
公告称，收入增长主要系报告期内稳定供应集采产品，销量持续增长。另外公司稳步推进国际市场的开拓工作，出口业务持续攀升。
净利增长主要系报告期内公司稳定供应集采产品、深度拓展国际市场，推动销量增长;同时内部降本增效，强化核心业务竞争力，内外并举推动盈利能力稳步提升，实现了净利润的持续增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.